Heart problems-focused Cleerly scored $192 million in Sequence C financing, a bit of greater than a yr after the corporate launched with a $43 million Series B.
The most recent spherical, led by T. Rowe Worth and Constancy Administration and Analysis Firm, brings Cleerly’s whole increase to $248 million.
Different individuals within the spherical embrace Sands Capital, Piper Sandler’s Service provider Banking and Heartland Healthcare Capital funds, Mirae Asset Capital, Peter Thiel, Breyer Capital, Novartis, Vensana Capital, LRVHealth, New Leaf Ventures, Cigna Ventures and DigiTx Companions.
The corporate affords an AI-backed device that evaluates CT angiograms for plaque build-up on the center arteries’ partitions, which Cleerly pitches as a option to catch coronary heart illness early. It’ll use the Sequence C capital to broaden its staff and business capabilities in addition to spend money on analysis.
“At Cleerly, we’re obsessed with our mission to create a brand new normal of take care of coronary heart illness,” CEO and founder Dr. James Min mentioned in an announcement. “We’re grateful for this spherical of financing that can additional allow our work and consider it gives a powerful vote of confidence in our imaginative and prescient for the way forward for cardiovascular care.
“The established order for coronary heart well being merely isn’t adequate – for sufferers, suppliers, or payors – and our confirmed method to analyzing for early indicators of coronary heart illness by means of the build-up of arterial plaque guarantees to ship the change we want proper now.”
Elation Health, which affords instruments for telehealth, affected person engagement, and an EHR geared towards major care suppliers, raised $50 million in Sequence D funding.
The spherical was led by Era Funding Administration and Ascension Ventures, with participation from Threshold Ventures, Ascend Companions, and particular person traders, together with Firefly Well being CEO Fay Rotenberg, and former athenahealth CEO and founder Jonathan Bush.
Elation most not too long ago scored $40 million in Series C financing in 2020. The most recent increase brings its whole funding pot to $108.5 million.
Affected person consumption chatbot Well being Observe closed a $17 million Sequence A funding spherical led by SignalFire.
Different traders within the spherical embrace UnityPoint Well being, Northwell Holdings and Cedars Sinai Well being Ventures.
The startup affords a platform that may message sufferers to substantiate their appointments, talk about well being historical past and issues, after which enter that info into the EHR earlier than their go to. Well being Observe will use the funding to hurry market growth, add EHR integrations, and spend money on analysis and growth so as to add to their instruments.
“The imaginative and prescient for Well being Observe has all the time been to assist care suppliers by empowering sufferers to create and work together with their well being information earlier than the go to begins, thus lowering the rising documentation burden that frustrates the overwhelming majority of medical doctors and care groups,” CEO and cofounder Dr. Joshua Reischer mentioned in an announcement.
“The extra funding will assist Well being Observe replicate its early success with mid-size practices and well being techniques at scale, which is sorely wanted as our well being system continues to function with restricted employees.”
Summer season Well being raised $7.5 million in seed funding for its messaging service that permits dad and mom to talk with pediatricians about their kid’s well being and growth. The service is now accessible in public beta testing.
The spherical was led by Alfred Lin at Sequoia Capital and Deena Shakir at Lux Capital, with participation from Field Group, Metrodora Ventures, Shrug Capital, Springbank Collective, Coalition Operators, Shifting Ventures, Maven founder and CEO Kate Ryder, Hims & Hers founder and CEO Andrew Dudum, Mos founder and CEO Amira Yahyaoui, and digital well being investor Alyssa Jaffee.
RxLive, which affords instruments for telepharmacy and drugs administration, scooped up $5 million in a Sequence A funding spherical, led by SpringTide, with participation from Cardinal Well being.
The startup plans to make use of the funds to rent for its engineering, analytics, and gross sales and advertising groups, and to enhance its remedy administration platform.
“With the transfer to value-based care, the in a single day adoption of telemedicine, and rising significance and emphasis on managing pharmacy spend, RxLive is placing scientific pharmacists again the place they belong,” RxLive cofounder and chief pharmacy officer Kristen Engelen mentioned in an announcement.
“We give sufferers the one-on-one remedy experience and a focus they should enhance high quality of life, and the expertise and providers healthcare organizations want to enhance outcomes.”
